Screener
Bausch + Lomb BLCO Vision Care — Selling, general and administrative (Note 4)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bausch + Lomb in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Bausch + Lomb’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001860742-26-000088
| (in millions) | Vision Care / Three Months Ended June 30, 2026 | Vision Care / Three Months Ended June 30, 2025 | Pharmaceuticals / Three Months Ended June 30, 2026 | Pharmaceuticals / Three Months Ended June 30, 2025 | Surgical / Three Months Ended June 30, 2026 | Surgical / Three Months Ended June 30, 2025 | Total / Three Months Ended June 30, 2026 | Total / Three Months Ended June 30, 2025 |
|---|---|---|---|---|---|---|---|---|
| Expenses | ||||||||
| Cost of goods sold (excluding amortization and impairments of intangible assets) | 291 | 290 | 89 | 104 | 147 | 129 | ||
| Cost of other revenues | — | — | — | 2 | — | — | ||
| Selling, general and administrative | 247 | 243 | 149 | 154 | 80 | 73 | ||
| Research and development | 17 | 11 | 27 | 12 | 12 | 12 | ||
| Segment Profit | $229 | $209 | $89 | $37 | $17 | $2 | 335 | 248 |
| Corporate | (170) | (170) | ||||||
| Amortization of intangible assets | (57) | (67) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Bausch + Lomb's vision care — selling, general and administrative (note 4)?
- Bausch + Lomb (BLCO) reported vision care — selling, general and administrative (note 4) of $247M in Q2 2026.
- How has Bausch + Lomb's vision care — selling, general and administrative (note 4) changed year-over-year?
- Bausch + Lomb's vision care — selling, general and administrative (note 4) increased by 1.6% year-over-year, from $243M to $247M.
- What is the long-term trend for Bausch + Lomb's vision care — selling, general and administrative (note 4)?
- Over 3 years (2022 to 2025), Bausch + Lomb's vision care — selling, general and administrative (note 4) has grown at a 5.2% compound annual growth rate (CAGR), from $784M to $912M.
- What does vision care — selling, general and administrative (note 4) mean?
- Includes all operating expenses related to the marketing, sales, and administrative support functions of the Vision Care segment. This metric reflects the overhead required to maintain the segment's market presence and distribution network. Investors monitor this to evaluate the efficiency of the segment's cost structure relative to its revenue generation.
Ask your AI about Bausch + Lomb's vision care — selling, general and administrative (note 4).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude